VaxGen Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: South San Francisco CA United States (1995)
Status: Acquired by diaDexus (2010)

Organization Overview

First Clinical Trial
1999
NCT00006327
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

VaxGen (v1) | VaxGen (v2)